Cross-border pharma deal calls on multiple LatAm firms
Canadian publicly owned specialty pharmaceuticals company Knight Therapeutics has hired Davies Ward Phillips & Vineberg in Montréal, Pinheiro Neto Advogados in São Paulo, Ferrere (Uruguay), Brigard Urrutia in Bogotá and Beccar Varela in Buenos Aires to buy a majority stake in Uruguayan biopharmaceutical group Biotoscana, in a deal valued at 1.1 billion Brazilian reais (US$273 million).
To read more
Subscribe to Latin Lawyer
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Latin Lawyer experts.